Advanced search
Publication Cover
Leukemia & Lymphoma Volume 57, 2016 - Issue 5
Submit an article Journal homepage
323
Views
5
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Does bendamustine impact the mobilization of peripheral blood stem cells? A multicenter retrospective study of 23 cases

Anne-Claire GacInstitut D’hématologie De Basse Normandie, Centre Hospitalier Universitaire, Caen, France;
,
Nabih AzarService D’hématologie Clinique, Centre Hospitalier Universitaire, La Pitié Salpetrière, Paris, France;
,
Etienne Daguindauervice D’hématologie Clinique, Centre Hospitalier Universitaire, Besançon, France ; Et INSERM UMR 1098, Université De Franche-Comté, Besançon, France;
,
Guillaume CartronDépartement D’hématologie Clinique, Centre Hospitalier Universitaire, UMR-CNRS, Montpelliers, France;
,
Luc M. ForneckerService D’hématologie Clinique, Centre Hospitalier Universitaire, Strasbourg, France;
,
Emmanuel GyanService D’hématologie Et Thérapie Cellulaire, Centre Hospitalier Universitaire, Tours, France;
,
Florence Broussais-GuillaumotService D’hématologie Clinique, Institut Paoli Calmettes, Marseille, France;
,
Reda GaridiService D’hématologie Clinique, Centre Hospitalier, Saint Quentin, France;
,
Bachra ChoufiService D’hématologie Clinique, Centre Hospitalier, Boulogne, France;
,
Sylvain P. ChantepieInstitut D’hématologie De Basse Normandie, Centre Hospitalier Universitaire, Caen, France;
,
Marie-Christine BénéLaboratoire D’hématologie, Centre Hospitalier Universitaire, Nantes, France;
,
Romain GuiézeService D’hématologie Clinique Adulte Et De Thérapie Cellulaire CHU De Clermont-Ferrand, France; EA7283 - CREAT, Université D’auvergne, Clermont-Ferrand, France;
,
Fontanet BijouService D’hématologie Clinique, Institut Bergonié, Bordeaux, France;
,
Remy GressinService D’hématologie Clinique, Centre Hospitalier Universitaire, Grenoble, France;
,
Sandy AmorimService D’hématologie Clinique, Centre Hospitalier Universitaire, Saint Louis, Paris, France;
&
Gandhi DamajInstitut D’hématologie De Basse Normandie, Centre Hospitalier Universitaire, Caen, France; ;Faculté De Médecine, Université Caen-Basse Normandie, Caen, FranceCorrespondence[email protected]
 show all
Pages 1149-1153 | Received 17 Sep 2015, Accepted 03 Jan 2016, Published online: 15 Feb 2016

References

  • Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009;114:937–951.
  • Montoto S, Corradini P, Dreyling M, et al. Indications for hematopoietic stem cell transplantation in patients with follicular lymphoma: a consensus project of the EBMT-Lymphoma Working Party. Haematologica. 2013;98:1014–1021.
  • Rummel MJ, Niederle N, Maschmeyer G, et al. Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial. Lancet. 2013;381:1203–1210.
  • Mian M, Farsad M, Pescosta N, et al. Bendamustine salvage for the treatment of relapsed Hodgkin's lymphoma after allogeneic bone marrow transplantation. Ann Hematol. 2013;92:121–123.
  • Elia GMD, De Angelis F, Breccia M, et al. Efficacy of bendamustine as salvage treatment in an heavily pre-treated Hodgkin lymphoma. Leukemia Res. 2010;34:e300–e301.
  • Leoni LM, Bailey B, Reifert J, et al. Bendamustine (Treanda) displays a distinct pattern of cytotoxicity and unique mechanistic features compared with other alkylating agents. Clin Cancer Res. 2008;14:309–317.
  • Perea G, Sureda A, Martino R, et al. Predictive factors for a successful mobilization of peripheral blood CD34 + cells in multiple myeloma. Ann Hematol. 2001;80:592–597.
  • Tournilhac O. Impact of frontline fludarabine and cyclophosphamide combined treatment on peripheral blood stem cell mobilization in B-cell chronic lymphocytic leukemia. Blood. 2004;103:363–365.
  • Green DJ, Bensinger WI, Holmberg L, et al. Bendamustine-based regimens are effective in mobilizing peripheral blood hematopoietic stem cells for autologous transplantation. ASH. 2013; Abstract book, 2033.
  • Visco C, Finotto S, Zambello R, et al. Combination of rituximab, bendamustine, and cytarabine for patients with mantle-cell non-Hodgkin lymphoma ineligible for intensive regimens or autologous transplantation. J Clin Oncol. 2013;31:1442–1449.
  • Anastasia A, Carlo-Stella C, Pulsoni A, et al. Mobilization of hematopoietic stem cells by bendamustine-containing regimens in Hodgkin's lymphoma: results update. EBMT. 2014; Abstract book, PH-P163.
  • LaCasce A, Bociek RG, Matous J, et al. Brentuximab vedotin in combination with bendamustine for patients with hodgkin lymphoma who are relapsed or refractory after frontline therapy. Blood. 2014;124:293–296.
  • Cheson BD, Rummel MJ. Bendamustine: rebirth of an old drug. J Clin Oncol. 2009;27:1492–1501.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.